<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04927819</url>
  </required_header>
  <id_info>
    <org_study_id>FIBEA_02_EP/20/Extracortos</org_study_id>
    <nct_id>NCT04927819</nct_id>
  </id_info>
  <brief_title>Extra-short vs. Non-extra-short Dental Implants Splinted on the Same Prosthesis</brief_title>
  <official_title>Prospective Observational Study on Evolution of Extra-short Implants (&lt;6.5 mm) Compared to Non-extra-short Implants (≥ 6.5 mm) Splinted on the Same Prosthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Eduardo Anitua</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Eduardo Anitua</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aim of this prospective study is to analyze the survival rate of short-length&#xD;
      implants (&lt;6.5 mm) in subjects with partial edentulism. Non-short length implant will be used&#xD;
      as control arm. Additionally, others clinical parameters (marginal bone loss and prosthetic&#xD;
      associated complications) will be measured.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 11, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival of dental implants</measure>
    <time_frame>1 year</time_frame>
    <description>Survival of dental implants at one year post-implantation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Marginal bone loss</measure>
    <time_frame>1 year</time_frame>
    <description>Marginal bone loss at one year post-implantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of prosthetic or implant complications</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">102</enrollment>
  <condition>Partial-edentulism</condition>
  <arm_group>
    <arm_group_label>short-length implant (&lt;6.5 mm)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non-short length implant (≥6.5 mm)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BTI Implant</intervention_name>
    <description>BTI Dental implants are non-active medical device, single use, non resterilizable, biocompatible and sterile devices made of alloplastic materials (Titanium) intended to be surgically implanted into alveolar and/or basal bone of the mandible or maxilla to provide support and a means of retention for a dental prosthesis (e.g. bridge, single-tooth, overdenture).</description>
    <arm_group_label>non-short length implant (≥6.5 mm)</arm_group_label>
    <arm_group_label>short-length implant (&lt;6.5 mm)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Partial edentulism&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Have planned a fixed multiple prosthesis supported by implants &lt;6.5 mm in length and&#xD;
             implants ≥ 6.5 mm in length within 15 days before the inclusion of the patient in the&#xD;
             study.&#xD;
&#xD;
          -  Planning of supported prostheses from 2 to 4 implants dental&#xD;
&#xD;
          -  Have a previously performed CBCT (Cone Beam Computed Tomography)&#xD;
&#xD;
          -  Availability to be observed during the period of tracing&#xD;
&#xD;
          -  Signature of the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smokers&gt; 10 cigarettes / day&#xD;
&#xD;
          -  Complete prostheses&#xD;
&#xD;
          -  Unitary prostheses&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Eduardo Anitua, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinica Eduardo Anitua</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mikel Allende, PhD</last_name>
    <phone>+34945160653</phone>
    <phone_ext>257</phone_ext>
    <email>mikel.allende@bti-implant.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mikel Allende</last_name>
    <phone>+34945160653</phone>
    <phone_ext>257</phone_ext>
    <email>mikel.allende@bti-implant.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinica Eduardo Anitua</name>
      <address>
        <city>Vitoria</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mikel Allende</last_name>
      <phone>+34945160653</phone>
      <email>mikel.allende@bti-implant.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 9, 2021</study_first_submitted>
  <study_first_submitted_qc>June 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2021</study_first_posted>
  <last_update_submitted>June 15, 2021</last_update_submitted>
  <last_update_submitted_qc>June 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

